These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12198692)

  • 1. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.
    Abreu MT; Taylor KD; Lin YC; Hang T; Gaiennie J; Landers CJ; Vasiliauskas EA; Kam LY; Rojany M; Papadakis KA; Rotter JI; Targan SR; Yang H
    Gastroenterology; 2002 Sep; 123(3):679-88. PubMed ID: 12198692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
    Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease.
    Weiss B; Shamir R; Bujanover Y; Waterman M; Hartman C; Fradkin A; Berkowitz D; Weintraub I; Eliakim R; Karban A
    J Pediatr; 2004 Aug; 145(2):208-12. PubMed ID: 15289769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
    Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
    Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease.
    Tomer G; Ceballos C; Concepcion E; Benkov KJ
    Am J Gastroenterol; 2003 Nov; 98(11):2479-84. PubMed ID: 14638352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients.
    Fidder HH; Olschwang S; Avidan B; Zouali H; Lang A; Bardan E; Picard O; Bar-Meir S; Colombel JF; Chowers Y
    Am J Med Genet A; 2003 Sep; 121A(3):240-4. PubMed ID: 12923865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
    Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
    Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
    Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
    Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
    Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
    Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease.
    Vavassori P; Borgiani P; Biancone L; D'Apice MR; Blanco Gdel V; Vallo L; De Nigris F; Monteleone I; Monteleone G; Pallone F; Novelli G
    Inflamm Bowel Dis; 2004 Mar; 10(2):116-21. PubMed ID: 15168811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.
    Büning C; Genschel J; Bühner S; Krüger S; Kling K; Dignass A; Baier P; Bochow B; Ockenga J; Schmidt HH; Lochs H
    Aliment Pharmacol Ther; 2004 May; 19(10):1073-8. PubMed ID: 15142196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
    Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status.
    Crawford NP; Colliver DW; Eichenberger MR; Funke AA; Kolodko V; Cobbs GA; Petras RE; Galandiuk S
    Dig Dis Sci; 2007 Oct; 52(10):2716-24. PubMed ID: 17404888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease.
    Ippoliti A; Devlin S; Mei L; Yang H; Papadakis KA; Vasiliauskas EA; McGovern DP; Abreu MT; Melmed G; Shaye O; Enayati P; Chen G; Choi J; Taylor K; Landers CJ; Rotter JI; Targan SR
    Inflamm Bowel Dis; 2010 Aug; 16(8):1279-85. PubMed ID: 20027650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
    Glas J; Seiderer J; Tillack C; Pfennig S; Beigel F; Jürgens M; Olszak T; Laubender RP; Weidinger M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Diegelmann J; Czamara D; Brand S
    PLoS One; 2010 Dec; 5(12):e14466. PubMed ID: 21209938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.
    Cuthbert AP; Fisher SA; Mirza MM; King K; Hampe J; Croucher PJ; Mascheretti S; Sanderson J; Forbes A; Mansfield J; Schreiber S; Lewis CM; Mathew CG
    Gastroenterology; 2002 Apr; 122(4):867-74. PubMed ID: 11910337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease.
    Russell RK; Drummond HE; Nimmo EE; Anderson N; Smith L; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset M; Mahdi G; Satsangi J
    Inflamm Bowel Dis; 2005 Nov; 11(11):955-64. PubMed ID: 16239840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.